Pant Research Group: Otolaryngology, Head & Neck Surgery Clinical Epigenetics
Our research
Professor Harshita Pant leads cutting-edge research in the Otolaryngology, Head & Neck Surgery Clinical Epigenetics group at the Adelaide Centre of Epigenetics (ACE), focussing on the epigenetic aspects of diseases affecting the airway and head and neck regions. Her research investigates the epigenetic influences that contribute to chronic airway inflammation (such as allergies, chronic rhinosinusitis (CRS), nasal polyps, and asthma) and head and neck cancer.
Our overarching goal is to bridge biomedical scientific discoveries with real-world clinical impact, offering personalised and transformative outcomes through a deeper understanding of individual patient’s disease.
Projects
Our projects are ideal for both undergraduate and postgraduate students from clinical and science backgrounds. We welcome highly motivated individuals who are passionate about research, embracing diverse perspectives and varying levels of experience—including those new to the field. With a proven track record in HDR supervision, we are committed to fostering a dynamic, supportive, and inspiring environment where students can learn, explore, and excel.
We have 3 main research themes:
-
Research Theme 1: AIRWAY INFLAMMATION : Chronic Rhinosinusitis and Asthma
Project 1. Reducing Steroid and Antibiotic Use in Rhinosinusitis and Asthma with Precision Medicine
Supervisors: Prof H Pant, Prof Paul Reynolds, Dr Damon Tumes, Prof Angel Lopez
Suitability: Honours, Masters and PhD candidates, from medical or science backgrounds. Prior laboratory experience is preferred but not required.
Collaborators: Dr Mark Schembri (Calvariam ENT), Prof Hubertus Jersmann (RAH), Dr Vinod Aiyappan and A/Prof Jeff Bowden (Flinders Medical Centre & SA Medical Specialists)
Location: Adelaide Health & Medical Sciences Building, North Terrace, Adelaide
Every sinusitis and asthma sufferer’s immunological environment is unique however current treatments are uniform, broad spectrum and often ineffective. This project aims to change that by undertaking a precision care based randomised-controlled clinical trial to reduce antibiotic and steroid use in sinusitis/asthma patients. By identifying specific inflammatory traits within patient’s airways using single-cell and spatial -omics, proteomics, and biochemical assays this project aims to inform and develop more personalised and effective treatments.
Project 2. Dissecting eosinophil heterogeneity in chronic allergic and non-allergic airway inflammation
Supervisors: Prof H Pant, Dr Damon Tumes, A/Prof Luciano Martelotto, Prof Angel Lopez
Collaborators: Dr Mark Schembri (Calvariam ENT), Prof Hubertus Jersmann (RAH), Dr Vinod Aiyappan and A/Prof Jeff Bowden (Flinders Medical Centre & SA Medical Specialists)
Suitability: Honours, Masters and PhD candidates, from medical or science backgrounds. Prior laboratory experience is preferred but not required.
Location: Bradley Building, North Terrace, Adelaide
Eosinophils are key immune cells that drive CRS, nasal polyps and asthma. Contrary to previous belief, they are more than just mediators of allergic inflammation—they are a complex and functionally diverse population of cells. This project offers the chance to re-define eosinophilic diseases by mapping their specific subpopulations and their roles in allergic and non-allergic inflammation, and in health and in disease. Using state-of-the-art cellular techniques and bioinformatics, this project aims to unlock eosinophil heterogeneity and inform new strategies for precision treatments.
-
Research Theme 2: HEAD AND NECK CANCER
Project 3. Overcoming immune exhaustion in head and neck cancer
Supervisors: Prof H Pant, Dr Carly Whyte, Dr Damon Tumes
Collaborators: A/Prof JC Hodge (ENT, CALHN), Dr James Badlani and Dr Paul Sambrook (OMF, CALHN)
Suitability: Honours, Masters and PhD candidates, from medical or science backgrounds. Prior laboratory experience is not required.
Location: Bradley Building, North Terrace, Adelaide
Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive cancer with high recurrence and poor survival rates. Current immunotherapies such as PD-1 inhibitors benefit only a minority of patients. This project offers a unique opportunity to re-define treatment for this challenging cancer by using spatial gene expression profiling of patient samples and animal models to uncover epigenetic drivers of T cell dysfunction and develop and test cell-based immunotherapies to reinvigorate anti-cancer T cells to improve their anti-cancer function.
Project 4. Cancer-associated fibroblasts and stromal components as predictors of occult metastasis in oral tongue squamous cell carcinoma
Supervisors: Prof H Pant, Dr Marina Kochetkova, Dr Adrienne Sullivan
Collaborators: A/Prof JC Hodge (ENT, CALHN), Dr James Badlani and Dr Paul Sambrook (OMF, CALHN)
Suitability: Honours, Masters and PhD candidates, from medical or science backgrounds. Prior laboratory experience is not required.
Location: Bradley Building, North Terrace, Adelaide
Neck lymph node metastasis is the key prognostic factor in oral tongue squamous cell carcinoma (OTSCC), yet current diagnostics fail to predict its occurrence. Cancer-associated fibroblasts (CAFs) are emerging as critical drivers of metastasis, aggressive cancer biology and poor outcomes. Using molecular and functional analyses of patient-derived samples we have identified distinct CAF populations that enhance tumour invasiveness. This project builds on these findings to investigate epigenetic mechanisms of metastasis, aiming to improve early detection of occult metastases and ultimately improve patient outcomes.
-
Research Theme 3: REGENERATIVE MEDICINE
Project 5. Reprogramming airway basal cells to improve barrier function
Supervisors: Prof H Pant, Dr Damon Tumes, Prof Jose Polo
Suitability: Honours, Masters and PhD candidates, from medical or science backgrounds. Prior laboratory experience is not essential.
Location: Adelaide Health & Medical Sciences Building, North Terrace, Adelaide
Functional ciliated respiratory epithelial system is critical for effective muco-ciliary function, maintaining homeostasis and barrier function. This project will utilise innovative molecular and cellular techniques to comprehensively characterise the respiratory epithelium to uncover epigenetic drivers of the reprogramming process into ciliated epithelium.
Highlighted publications
- Pant H, Herus TR, Tumes DJ, Yip KH, Parker MW, Owczarek CM, Lopez AF and Huston DP. Translating the biology of β common receptor-engaging cytokines into clinical medicine, 2023, Journal of Allergy and Clinical Immunology, Volume 151, Issue 2, 324 - 344.
- Kan WL, Weekley CM, Nero TL, Hercus TR, Yip KH, Tumes DJ, Woodcock JM, Ross DM, Thomas D, Terán D, Owczarek CM, Liu NW, Martelotto LG, Polo JM, Pant H, Tvorogov D, Lopez A, Parker MW, The β Common Cytokine Receptor Family Reveals New Functional Paradigms From Structural Complexities, 2025, Immunological Reviews 329 (1), e13430
- Cildir G, Yip KH , Pant H , Tergaonkar V, Lopez AF Tumes DJ. Understanding mast cell heterogeneity at single cell resolution, 2021, Trends in Immunology 42 (6), 523-535